GenSpera, Inc. (GenSpera)

Oncology Corporate Profile

HQ Location

2511 N. Loop 1604 W., Suite 204
San Antonio, TX 78258

Company Description

GenSpera, Inc. is a San Antonio-based biotech company that unlocks conventional thinking to conceive, design, and develop cancer therapies. GenSpera's technology platform combines a powerful, plant-derived cytotoxin (thapsigargin) with a patented prodrug delivery system that provides for targeted release of drug candidates within tumors.


This company does not have any commercial products
  • Brand
  • Generic
  • Investigational
Brand / Product Class Area of Study Phase Partnership
mipsagargin / G-202PSA activated prodrugGlioblastoma Multiforme (GBM)II
mipsagargin / G-202PSA activated prodrugHepatocellular carcinoma (HCC)II
mipsagargin / G-202PSA activated prodrugProstate cancerI
G-115PSA activated prodrugProstate cancerPreclinical

View additional information on product candidates here »


Recent News Headlines

There are no news items to display